Does Antidepressant Use Blunt Adaptations to Exercise?

NCT ID: NCT03934723

Last Updated: 2019-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-15

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nearly one out of ten US adults over the age of 18 currently takes antidepressant medication, which can also treat other conditions such as anxiety. Combining pharmaceutical treatment with exercise may yield even greater benefits than using drugs alone, and this is commonly prescribed for depression. However, little is known about the drug-exercise interactions and their influence on metabolic health. A common side effect of antidepressant use is weight gain, particularly abdominal (visceral) fat, which is highly detrimental to overall health. Exercise is a well-known counter to abdominal fat accumulation. The aim of the proposed study is to compare the efficacy of 6 weeks of exercise training to reduce abdominal fat in healthy overweight/obese adults either taking or not taking antidepressant medication. Twenty-four inactive overweight/obese, but otherwise healthy, adults will complete 6 weeks of an exercise training intervention consisting of three days of aerobic exercise training per week. Participants will either not be taking antidepressant medication or will have been on their medication for at least 1 year. The primary outcome will be abdominal fat determined by waist circumference and dual x-ray absorptiometry, which is considered one of the optimal methods for assessment of abdominal fat.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Depressive Disorder Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

This arm will consist of healthy overweight and obese individuals who are physically inactive and do not have clinically diagnosed depression or depression symptoms.

Group Type ACTIVE_COMPARATOR

Exercise

Intervention Type BEHAVIORAL

The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.

Antidpressants

This arm will consist of healthy overweight and obese adults who are physically inactive and who are diagnosed with clinical depression and have been taking antidepressant medications for at least 1 year.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

The intervention consists of 180 minutes of moderate-vigorous aerobic exercise per week for 6 weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants will be English language speakers
* Male or females between the ages of 18-40.
* All genders and ethnicities.
* Healthy as assessed by a health history questionnaire (no diagnosed physical diseases or conditions preventing participation in exercise).
* Individuals on antidepressants will be recruited if they are consuming selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) only. Participants will send prescription information after consent has been provided as part of the screening process, including the dose and frequency of medication.
* A body mass index (BMI) of 25 or greater is required for inclusion.

Exclusion Criteria

* Inability to complete moderate-vigorous exercise.
* Taking first generation antidepressant medications or other medications such as monoamine oxidase inhibitors (MAOI).
* Other medications, such as medications for attention-deficit hyper-activity disorder or metabolism
* Undiagnosed depression that may be unveiled during the screening process.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

California State University, San Marcos

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Matthew Schubert

Assistant Professor of Kinesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

California State University San Marcos

San Marcos, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dean of Graduate Studies and Research

Role: CONTACT

(760) 750-4066

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matthew M Schubert, Ph.D.

Role: primary

760-750-7362

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1423972-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Depression Outcomes Study of Exercise
NCT00964054 COMPLETED PHASE1
CBT+ for Depression
NCT06001346 COMPLETED NA
Holistic Approaches to Depression
NCT01384916 COMPLETED PHASE2